Aztreonam:
Intravenous monobactam
ECMO Dose Adjustment:
NONE
Renal Impairment Dose Adjustment*:
YES—a decreased dose may be warranted in some patients
CRRT Dose Adjustment:
YES—the dose may need to be increased relative to the renal impairment dose
Hepatic Impairment Dose Adjustment:
NONE
Adult Dose:
2 g IV every 8 hours
Pediatric Dose:
30 mg/kg IV every 6–8 hours, maximum 2 g/dose or 8 g/day
Neonatal Dose:
30 mg/kg/dose IV
Postmenstrual Age ≤29 weeks:
- Postnatal Age ≤ 28 days: every 12 hours
- Postnatal Age > 28 days: every 8 hours
Postmenstrual Age 30 to 36 weeks:
- Postnatal Age ≤ 14 days: every 12 hours
- Postnatal Age > 14 days: every 8 hours
Postmenstrual Age 37 to 44 weeks:
- Postnatal Age ≤ 7 days: every 12 hours
- Postnatal Age > 7 days: every 8 hours
Postmenstrual age ≥ 45 weeks: every 6 hours